Gambaran Umum
MediWound Ltd. is a biopharmaceutical company based in Israel, specializing in the development, manufacture, and commercialization of novel products to address unmet needs in the fields of severe burns, chronic wound management, and connective tissue disorders. The company's flagship product, NexoBrid, is an innovative enzymatic treatment that selectively removes burnt tissue in patients with severe burns. It has gained regulatory approval and market access in multiple international territories. Additionally, MediWound is actively working on expanding its product portfolio with EscharEx, a topically applied cream for debridement of chronic and other hard-to-heal wounds, which is currently in advanced stages of clinical trials. The company's focus on enzymatic technology underpins its therapeutic advancements, aligning with its strategic vision to lead in specialized wound care solutions.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk MediWound Ltd. per 2025 Jun 30 adalah 19.86 MM.
- Nilai operating income untuk MediWound Ltd. per 2025 Jun 30 adalah -22.12 MM.
- Nilai net income untuk MediWound Ltd. per 2025 Jun 30 adalah -28.23 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 19.86 | -22.12 | -28.23 |
2025-03-31 | 19.21 | -20.89 | -21.22 |
2024-12-31 | 20.22 | -19.40 | -30.22 |
2024-09-30 | 19.72 | -17.40 | -28.06 |
2024-06-30 | 20.14 | -15.35 | -19.97 |
2024-03-31 | 19.85 | -14.87 | -12.75 |
2023-12-31 | 18.69 | -15.50 | -6.72 |
2023-09-30 | 24.97 | -8.38 | -12.43 |
2023-06-30 | 25.99 | -8.87 | -14.43 |
2023-03-31 | 25.89 | -8.54 | -19.70 |
2022-12-31 | 26.50 | -7.66 | -19.60 |
2022-09-30 | 20.36 | -13.69 | -16.30 |
2022-06-30 | 20.93 | -13.36 | -15.45 |
2022-03-31 | 22.32 | -12.58 | -14.29 |
2021-12-31 | 23.76 | -11.22 | -13.55 |
2021-09-30 | 24.95 | -9.84 | -11.12 |
2021-06-30 | 25.20 | -8.50 | -9.69 |
2021-03-31 | 23.17 | -8.31 | -9.59 |
2020-12-31 | 21.76 | -8.84 | -9.20 |
2020-09-30 | 20.53 | -8.43 | -10.91 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk MediWound Ltd. pada 2025 Jun 30 adalah -2.63.
- laba per saham yang terdilusi untuk MediWound Ltd. pada 2025 Jun 30 adalah -2.63.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -2.63 | -2.63 |
2025-03-31 | -2.05 | -2.05 |
2024-12-31 | -3.03 | |
2024-09-30 | -2.93 | -2.93 |
2024-06-30 | -2.16 | -2.16 |
2024-03-31 | -1.38 | -1.38 |
2023-12-31 | -0.75 | |
2023-09-30 | -1.50 | -1.50 |
2023-06-30 | -2.01 | -2.01 |
2023-03-31 | -3.25 | -3.25 |
2022-12-31 | -3.93 | |
2022-09-30 | -3.71 | -3.71 |
2022-06-30 | -3.71 | -3.71 |
2022-03-31 | -3.62 | -3.62 |
2021-12-31 | -3.48 | |
2021-09-30 | -2.86 | -2.86 |
2021-06-30 | -2.49 | -2.49 |
2021-03-31 | -2.47 | -2.47 |
2020-12-31 | -2.38 | |
2020-09-30 | -2.81 | -2.81 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk MediWound Ltd. per 2025 Jun 30 adalah -15.26 MM.
- Nilai cash from investing activities untuk MediWound Ltd. per 2025 Jun 30 adalah -7.90 MM.
- Nilai kas dari aktivitas pendanaan untuk MediWound Ltd. per 2025 Jun 30 adalah 20.38 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -15.26 | -7.90 | 20.38 |
2025-03-31 | -13.13 | -9.96 | 19.73 |
2024-12-31 | -13.62 | -8.40 | 19.39 |
2024-09-30 | -14.60 | -8.20 | 19.70 |
2024-06-30 | -14.10 | 0.26 | -1.73 |
2024-03-31 | -15.72 | -28.66 | -2.04 |
2023-12-31 | -10.46 | -34.32 | 22.92 |
2023-09-30 | -5.85 | -36.95 | 37.76 |
2023-06-30 | -7.17 | -31.20 | 50.26 |
2023-03-31 | -7.17 | -7.76 | 49.94 |
2022-12-31 | -11.88 | -0.48 | 35.76 |
2022-09-30 | -16.12 | -2.99 | 20.95 |
2022-06-30 | -14.37 | -3.04 | 8.82 |
2022-03-31 | -10.07 | -0.43 | 9.34 |
2021-12-31 | -8.92 | 3.55 | -1.05 |
2021-09-30 | -10.00 | 13.35 | -0.85 |
2021-06-30 | -6.14 | 10.79 | -0.77 |
2021-03-31 | -8.01 | 18.36 | -0.71 |
2020-12-31 | -6.89 | 17.39 | -0.63 |
2020-09-30 | -5.87 | 10.12 | -1.38 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk MediWound Ltd. pada 2025 Jun 30 adalah 6.70.
- p/tbv untuk MediWound Ltd. pada 2025 Jun 30 adalah 6.71.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 6.70 | 6.71 | |
2025-03-31 | 5.53 | 5.55 | |
2024-12-31 | 5.64 | 5.66 | |
2024-09-30 | -9.49 | 10.61 | 10.68 |
2024-06-30 | -11.28 | 6.20 | 6.24 |
2024-03-31 | -19.64 | 4.17 | 4.20 |
2023-12-31 | -7.54 | 2.84 | 2.85 |
2023-09-30 | -7.14 | 2.95 | 2.97 |
2023-06-30 | -4.85 | 8.72 | 8.90 |
2023-03-31 | -6.32 | 11.35 | |
2022-12-31 | 47.30 | 55.63 | |
2022-09-30 | -25.32 | -22.65 | |
2022-06-30 | 31.52 | 36.85 | |
2022-03-31 | -4.89 | -14.46 | -13.58 |
2021-12-31 | -5.83 | -78.99 | -57.13 |
2021-09-30 | -9.40 | 42.96 | 50.89 |
2021-06-30 | |||
2021-03-31 | -5.00 | 9.96 | 10.73 |
2020-12-31 | -5.21 | 6.59 | 6.94 |
2020-09-30 | -4.39 | 5.56 | 5.81 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk MediWound Ltd. pada 2025 Jun 30 adalah -0.12.
- EBIT (3 tahun) / EV untuk MediWound Ltd. pada 2025 Jun 30 adalah -0.11.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.12 | -0.11 |
2025-03-31 | -0.18 | -0.13 |
2024-12-31 | -0.15 | -0.10 |
2024-09-30 | -0.11 | -0.09 |
2024-06-30 | -0.12 | -0.14 |
2024-03-31 | -0.05 | -0.11 |
2023-12-31 | -0.15 | -0.16 |
2023-09-30 | -0.17 | -0.16 |
2023-06-30 | -0.32 | -0.24 |
2023-03-31 | -0.22 | -0.16 |
2022-12-31 | -0.26 | -0.20 |
2022-09-30 | -0.32 | -0.26 |
2022-06-30 | -0.32 | -0.27 |
2022-03-31 | -0.24 | -0.12 |
2021-12-31 | -0.22 | -0.12 |
2021-09-30 | -0.13 | -0.04 |
2021-06-30 | ||
2021-03-31 | -0.32 | -0.12 |
2020-12-31 | -0.30 | -0.14 |
2020-09-30 | -0.30 | -0.12 |
Efektivitas Manajemen
- roa untuk MediWound Ltd. pada 2025 Jun 30 adalah -0.37.
- roe untuk MediWound Ltd. pada 2025 Jun 30 adalah -1.19.
- roic untuk MediWound Ltd. pada 2025 Jun 30 adalah -0.56.
- croic untuk MediWound Ltd. pada 2025 Jun 30 adalah -0.09.
- ocroic untuk MediWound Ltd. pada 2025 Jun 30 adalah -0.34.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.37 | -1.19 | -0.56 | -0.09 | -0.34 |
2025-03-31 | -0.48 | -1.30 | -0.79 | -0.07 | -0.36 |
2024-12-31 | -0.42 | -0.89 | -0.69 | -0.07 | -0.36 |
2024-09-30 | -0.30 | -0.60 | -0.82 | -0.63 | -0.58 |
2024-06-30 | -0.19 | -0.38 | -0.43 | -1.55 | -0.53 |
2024-03-31 | -0.13 | -0.62 | -0.18 | -0.58 | -0.27 |
2023-12-31 | -0.43 | -7.51 | -0.32 | -0.14 | -0.15 |
2023-09-30 | -0.68 | -0.41 | 0.32 | -0.20 | |
2023-06-30 | -0.93 | -0.40 | 0.32 | -0.20 | |
2023-03-31 | -0.74 | -10.08 | -0.57 | 0.99 | -0.21 |
2022-12-31 | -0.70 | -6.25 | 0.47 | -6.18 | |
2022-09-30 | -0.67 | -6.25 | |||
2022-06-30 | -0.55 | -6.75 | |||
2022-03-31 | -0.46 | -2.81 | -3.78 | ||
2021-12-31 | -0.36 | -1.53 | -15.10 | ||
2021-09-30 | -0.31 | -1.12 | -4.40 | 1.16 | -1.65 |
2021-06-30 | -0.28 | -0.96 | -2.26 | 1.02 | -1.43 |
2021-03-31 | -0.25 | -0.74 | -1.37 | 1.39 | -1.15 |
2020-12-31 | -0.23 | -0.61 | -0.85 | 0.94 | -0.64 |
2020-09-30 | -0.25 | -0.60 | -0.94 | 0.26 | -0.50 |
Gross Margins
- marjin kotor untuk MediWound Ltd. pada 2025 Jun 30 adalah 0.14.
- marjin bersih untuk MediWound Ltd. pada 2025 Jun 30 adalah -1.10.
- marjin operasi untuk MediWound Ltd. pada 2025 Jun 30 adalah -1.09.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.14 | -1.10 | -1.09 |
2025-03-31 | 0.13 | -1.49 | -0.96 |
2024-12-31 | 0.12 | -1.42 | -0.88 |
2024-09-30 | 0.13 | -0.99 | -0.76 |
2024-06-30 | 0.17 | -0.64 | -0.75 |
2024-03-31 | 0.19 | -0.36 | -0.83 |
2023-12-31 | 0.44 | -0.50 | -0.34 |
2023-09-30 | 0.48 | -0.56 | -0.34 |
2023-06-30 | 0.50 | -0.56 | -0.34 |
2023-03-31 | 0.50 | -0.76 | -0.33 |
2022-12-31 | 0.32 | -0.80 | -0.67 |
2022-09-30 | 0.31 | -0.80 | -0.67 |
2022-06-30 | 0.35 | -0.74 | -0.62 |
2022-03-31 | 0.37 | -0.64 | -0.56 |
2021-12-31 | 0.38 | -0.57 | -0.47 |
2021-09-30 | 0.39 | -0.45 | -0.39 |
2021-06-30 | 0.39 | -0.38 | -0.34 |
2021-03-31 | 0.38 | -0.41 | -0.36 |
2020-12-31 | 0.35 | -0.42 | -0.41 |
2020-09-30 | 0.31 | -0.53 | -0.41 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1593984 |
Grupong Pang-industriya
SIC 2833 - Medicinal Chemicals and Botanical Products |